A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Boston Scientific Corp’s current trading price is -5.78% away from its 52-week high, while its distance from the 52-week low is 36.06%. The stock’s price range for this time frame has been between $75.44 and $108.94. The trading volume of the company’s shares in the Healthcare reached around 6.45 million for the day, which was evidently lower than the average daily volume of 7.45 million over the last three months.
The current stock price for Boston Scientific Corp (BSX) is $102.64. The stock experienced a significant increase during the last trading session, reaching $140.0 after opening at $102.64. It dipped to a low of $99.0 before ultimately closing at $102.75.
The stock market performance of Boston Scientific Corp has been very steady. Over the last year, the company’s stock hit its highest at $108.94 on 07/23/25, while the lowest price during the same time frame was $75.44, recorded on 08/14/24.
How Financial Performance Impacts Market Capitalization
Boston Scientific Corp (BSX) has experienced a quarterly decline of -0.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 152.09B and boasts a workforce of 53000 employees.
Decoding Analysts’ Ratings for Boston Scientific Corp
As of right now, 24 analysts are rating Boston Scientific Corp as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 102.15, with a change in price of +1.91. Similarly, Boston Scientific Corp recorded 7,907,932 in trading volume during the last 100 days, posting a change of +1.90%.
How BSX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.54. Similarly, the long-term debt-to-equity ratio is also 0.52.
BSX Stock Stochastic Average
Boston Scientific Corp’s raw stochastic average for the past 50 days is currently at 42.41%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 14.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 16.94% and 18.21%, respectively.
BSX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 35.86% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -3.33%. Over the past 30 days, the price of BSX has leaped by -1.62%. And in the last five days, it has fallen by -2.09%.
